HURA TuHURA Biosciences Inc.
Price (delayed)
$3.48
Market cap
$152.01M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.21
Enterprise value
$139.55M
Highlights
The quick ratio has soared by 132% YoY and by 77% from the previous quarter
The debt has dropped by 91% year-on-year
TuHURA Biosciences's EPS has plunged by 101% from the previous quarter but it has soared by 51% YoY
Key stats
What are the main financial stats of HURA
Market
Valuations
Earnings
Shares outstanding
43.68M
Market cap
$152.01M
Enterprise value
$139.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
10.08
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$17.65M
Net income
-$21.68M
EBIT
-$17.54M
EBITDA
-$17.43M
Free cash flow
-$14.79M
Per share
Balance sheet
Liquidity
EPS
-$1.21
EPS diluted
-$1.21
Free cash flow per share
-$0.79
Book value per share
$0.35
Revenue per share
$0
TBVPS
$1.07
Total assets
$19.97M
Total liabilities
$5.37M
Debt
$202,542
Equity
$14.59M
Working capital
$14.28M
Debt to equity
0.01
Current ratio
3.68
Quick ratio
2.37
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-240%
Return on equity
-348.9%
Return on invested capital
N/A
Return on capital employed
-119.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HURA stock price
How has the TuHURA Biosciences stock price performed over time
Intraday
19.59%
1 week
-2.25%
1 month
44.4%
1 year
-97.17%
YTD
-14.91%
QTD
7.74%
Financial performance
How have TuHURA Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$17.65M
Net income
-$21.68M
Gross margin
N/A
Net margin
N/A
TuHURA Biosciences's operating income has increased by 41% YoY and by 34% QoQ
The net income rose by 26% YoY and by 17% QoQ
Growth
What is TuHURA Biosciences's growth rate over time
Valuation
What is TuHURA Biosciences stock price valuation
P/E
N/A
P/B
10.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TuHURA Biosciences's EPS has plunged by 101% from the previous quarter but it has soared by 51% YoY
The P/B is 65% higher than the 5-year quarterly average of 5.1 and 48% higher than the last 4 quarters average of 5.7
Efficiency
How efficient is TuHURA Biosciences business performance
HURA's return on equity has surged by 97% year-on-year and by 67% since the previous quarter
HURA's ROA has soared by 66% YoY and by 49% QoQ
Dividends
What is HURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HURA.
Financial health
How did TuHURA Biosciences financials performed over time
The current ratio has surged by 139% since the previous quarter
The quick ratio has soared by 132% YoY and by 77% from the previous quarter
The debt is 99% smaller than the equity
The debt to equity has surged by 101% year-on-year
The debt has dropped by 91% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.